{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T05:33:19Z","timestamp":1785043999722,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Public Health Clinical Center","award":["KY-GW-2024-05"],"award-info":[{"award-number":["KY-GW-2024-05"]}]},{"name":"Science and Technology Plan Project of Zhejiang Province","award":["2022C03189"],"award-info":[{"award-number":["2022C03189"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11598-8","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:56:45Z","timestamp":1759921005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bioinformatics analysis of the proteome in the pathway of complement and coagulation cascades in COVID-19: discovering potential biomarkers of FGB and SERPINA5"],"prefix":"10.1186","volume":"25","author":[{"given":"Siyuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huichun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuisong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"11598_CR1","doi-asserted-by":"crossref","unstructured":"Chung YS, Lam CY, Tan PH et al. Comprehensive review of COVID-19: epidemiology, pathogenesis, advancement in diagnostic and detection techniques, and Post-Pandemic treatment strategies. Int J Mol Sci. 2024; 25:8155.","DOI":"10.3390\/ijms25158155"},{"key":"11598_CR2","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/s41591-022-01909-w","volume":"28","author":"A Subramanian","year":"2022","unstructured":"Subramanian A, Nirantharakumar K, Hughes S, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28:1706\u201314.","journal-title":"Nat Med"},{"key":"11598_CR3","doi-asserted-by":"publisher","first-page":"e31878","DOI":"10.1016\/j.heliyon.2024.e31878","volume":"10","author":"S Song","year":"2024","unstructured":"Song S, Zeng L, Xu J, et al. Proteomic lung analysis revealed hyper-activation of neutrophil extracellular trap formation in cases of fatal COVID-19. Heliyon. 2024;10:e31878.","journal-title":"Heliyon"},{"key":"11598_CR4","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1080\/07391102.2020.1832919","volume":"40","author":"MA Hendaus","year":"2022","unstructured":"Hendaus MA, Jomha FA. From COVID-19 to clot: the involvement of the complement system. J Biomol Struct Dyn. 2022;40:1909\u201314.","journal-title":"J Biomol Struct Dyn"},{"key":"11598_CR5","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s10067-020-05190-5","volume":"39","author":"M Soy","year":"2020","unstructured":"Soy M, Keser G, Atagunduz P, et al. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol. 2020;39:2085\u201394.","journal-title":"Clin Rheumatol"},{"key":"11598_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.14712\/23362936.2023.7","volume":"124","author":"A Ray","year":"2023","unstructured":"Ray A, Winter KAK, Naik DSL, et al. Prognostic significance of the coagulation and complement systems in critical COVID-19 infection. Prague Med Rep. 2023;124:77\u201393.","journal-title":"Prague Med Rep"},{"key":"11598_CR7","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","volume":"74","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev Esp Cardiol (Engl Ed). 2021;74:790\u20139.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"11598_CR8","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504.","journal-title":"Genome Res"},{"key":"11598_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2105-4-2","volume":"4","author":"GD Bader","year":"2003","unstructured":"Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 2003;4:2.","journal-title":"BMC Bioinformatics"},{"issue":"Suppl 4","key":"11598_CR10","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH, et al. CytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11.","journal-title":"BMC Syst Biol"},{"key":"11598_CR11","doi-asserted-by":"publisher","first-page":"D1353","DOI":"10.1093\/nar\/gkac1046","volume":"51","author":"D Ochoa","year":"2023","unstructured":"Ochoa D, Hercules A, Carmona M, et al. The next-generation open targets platform: reimagined, redesigned, rebuilt. Nucleic Acids Res. 2023;51:D1353\u20139.","journal-title":"Nucleic Acids Res"},{"key":"11598_CR12","doi-asserted-by":"publisher","first-page":"100779","DOI":"10.1016\/j.xcrm.2022.100779","volume":"3","author":"TJ LaSalle","year":"2022","unstructured":"LaSalle TJ, Gonye ALK, Freeman SS, et al. Longitudinal characterization of Circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patients. Cell Rep Med. 2022;3:100779.","journal-title":"Cell Rep Med"},{"key":"11598_CR13","doi-asserted-by":"publisher","first-page":"eadl5762","DOI":"10.1126\/sciadv.adl5762","volume":"10","author":"A Viode","year":"2024","unstructured":"Viode A, Smolen KK, van Zalm P, et al. Longitudinal plasma proteomic analysis of 1117 hospitalized patients with COVID-19 identifies features associated with severity and outcomes. Sci Adv. 2024;10:eadl5762.","journal-title":"Sci Adv"},{"key":"11598_CR14","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1021\/acs.jproteome.0c00365","volume":"19","author":"A D\u2019Alessandro","year":"2020","unstructured":"D\u2019Alessandro A, Thomas T, Dzieciatkowska M, et al. Serum proteomics in COVID-19 patients: altered coagulation and complement status as a function of IL-6 level. J Proteome Res. 2020;19:4417\u201327.","journal-title":"J Proteome Res"},{"key":"11598_CR15","doi-asserted-by":"publisher","first-page":"e14167","DOI":"10.15252\/emmm.202114167","volume":"13","author":"PE Geyer","year":"2021","unstructured":"Geyer PE, Arend FM, Doll S, et al. High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion. EMBO Mol Med. 2021;13:e14167.","journal-title":"EMBO Mol Med"},{"key":"11598_CR16","doi-asserted-by":"publisher","first-page":"16826","DOI":"10.1021\/acsomega.1c01375","volume":"6","author":"B Xu","year":"2021","unstructured":"Xu B, Lei Y, Ren X, et al. SOD1 is a possible predictor of COVID-19 progression as revealed by plasma proteomics. ACS Omega. 2021;6:16826\u201336.","journal-title":"ACS Omega"},{"key":"11598_CR17","doi-asserted-by":"publisher","first-page":"119046","DOI":"10.1016\/j.lfs.2021.119046","volume":"269","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Wang T, Liu F, et al. The proteomic characteristics of airway mucus from critical ill COVID-19 patients. Life Sci. 2021;269:119046.","journal-title":"Life Sci"},{"key":"11598_CR18","doi-asserted-by":"crossref","unstructured":"Ayass MA, Cao W, Zhang J et al. Noninvasive nasopharyngeal proteomics of COVID-19 patient identify abnormalities related to complement and coagulation cascade and mucosal immune system. PLoS ONE. 2022;17:e0274228.","DOI":"10.1371\/journal.pone.0274228"},{"key":"11598_CR19","doi-asserted-by":"crossref","unstructured":"Moraes E, Martins-Gon\u00e7alves R, da Silva LR et al. Proteomic profile of procoagulant extracellular vesicles reflects complement system activation and platelet hyperreactivity of patients with severe COVID-19. Frontiers in cellular and infection microbiology. 2022;12:926352.","DOI":"10.3389\/fcimb.2022.926352"},{"key":"11598_CR20","doi-asserted-by":"crossref","unstructured":"Wu S, Xu Y, Zhang J et al. Longitudinal serum proteome characterization of COVID-19 patients with different severities revealed potential therapeutic strategies. Front Immunol. 2022;13:893943.","DOI":"10.3389\/fimmu.2022.893943"},{"key":"11598_CR21","first-page":"258","volume":"116","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Lin F, Liu F, et al. Proteomic profiling reveals a distinctive molecular signature for critically ill COVID-19 patients compared with asthma and chronic obstructive pulmonary disease. Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis. 2022;116:258\u201367.","journal-title":"Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis"},{"key":"11598_CR22","doi-asserted-by":"publisher","first-page":"e15224","DOI":"10.1016\/j.heliyon.2023.e15224","volume":"9","author":"B Alghanem","year":"2023","unstructured":"Alghanem B, Mansour FA, Shaibah H, et al. Quantitative proteomics analysis of COVID-19 patients: Fetuin-A and tetranectin as potential modulators of innate immune responses. Heliyon. 2023;9:e15224.","journal-title":"Heliyon"},{"key":"11598_CR23","doi-asserted-by":"publisher","first-page":"2200070","DOI":"10.1002\/prca.202200070","volume":"17","author":"AT Sahin","year":"2023","unstructured":"Sahin AT, Yurtseven A, Dadmand S, et al. Plasma proteomics identify potential severity biomarkers from COVID-19 associated network. Proteom \u2013 Clin Appl. 2023;17:2200070.","journal-title":"Proteom \u2013 Clin Appl"},{"key":"11598_CR24","doi-asserted-by":"publisher","first-page":"e29219","DOI":"10.1002\/jmv.29219","volume":"95","author":"B Wang","year":"2023","unstructured":"Wang B, Yang W, Tong Y, et al. Integrative proteomics and metabolomics study reveal enhanced immune responses by COVID-19 vaccine booster shot against Omicron SARS-CoV-2 infection. J Med Virol. 2023;95:e29219.","journal-title":"J Med Virol"},{"key":"11598_CR25","doi-asserted-by":"publisher","first-page":"e29756","DOI":"10.1002\/jmv.29756","volume":"96","author":"A Blangy-Letheule","year":"2024","unstructured":"Blangy-Letheule A, Vergnaud A, Dupas T, et al. Value of a secretomic approach for distinguishing patients with COVID-19 viral pneumonia among patients with respiratory distress admitted to intensive care unit. J Med Virol. 2024;96:e29756.","journal-title":"J Med Virol"},{"key":"11598_CR26","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1089\/vim.2023.0094","volume":"37","author":"N Guo","year":"2024","unstructured":"Guo N, Han X, Han G, et al. Bioinformation analysis of differential expression proteins in different processes of COVID-19. Viral Immunol. 2024;37:194\u2013201.","journal-title":"Viral Immunol"},{"key":"11598_CR27","doi-asserted-by":"crossref","unstructured":"Pushalkar S, Wu S, Maity S et al. Complex changes in serum protein levels in COVID-19 convalescents. Sci Rep. 2024;14:4479.","DOI":"10.1038\/s41598-024-54534-7"},{"key":"11598_CR28","doi-asserted-by":"crossref","unstructured":"Yang Q, Lin Z, Xue M et al. Deciphering the Omicron variant: integrated omics analysis reveals critical biomarkers and pathophysiological pathways. J Translational Med 2024;22:219.","DOI":"10.1186\/s12967-024-05022-z"},{"key":"11598_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12014-023-09403-2","volume":"20","author":"G Hirdman","year":"2023","unstructured":"Hirdman G, Boden E, Kjellstrom S, et al. Proteomic characteristics and diagnostic potential of exhaled breath particles in patients with COVID-19. Clin Proteomics. 2023;20:13.","journal-title":"Clin Proteomics"},{"key":"11598_CR30","doi-asserted-by":"crossref","unstructured":"Kaiser R, Leunig A, Pekayvaz K et al. Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19. JCI Insight 2021;6:e150862.","DOI":"10.1172\/jci.insight.150862"},{"key":"11598_CR31","doi-asserted-by":"publisher","first-page":"e17459","DOI":"10.15252\/emmm.202317459","volume":"15","author":"L Schweizer","year":"2023","unstructured":"Schweizer L, Schaller T, Zwiebel M, et al. Quantitative multiorgan proteomics of fatal COVID-19 uncovers tissue-specific effects beyond inflammation. EMBO Mol Med. 2023;15:e17459.","journal-title":"EMBO Mol Med"},{"key":"11598_CR32","doi-asserted-by":"publisher","first-page":"1470193","DOI":"10.3389\/fmicb.2024.1470193","volume":"15","author":"Y Wei","year":"2024","unstructured":"Wei Y, Gu H, Ma J, et al. Proteomic and metabolomic profiling of plasma uncovers immune responses in patients with long COVID-19. Front Microbiol. 2024;15:1470193.","journal-title":"Front Microbiol"},{"key":"11598_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/ITT.S284830","volume":"10","author":"S Fodil","year":"2021","unstructured":"Fodil S, Annane D. Complement Inhibition and COVID-19: the story so Far. Immunotargets Ther. 2021;10:273\u201384.","journal-title":"Immunotargets Ther"},{"key":"11598_CR34","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.3389\/fimmu.2020.02072","volume":"11","author":"P Urwyler","year":"2020","unstructured":"Urwyler P, Moser S, Charitos P, et al. Treatment of COVID-19 with conestat alfa, a regulator of the complement, contact activation and Kallikrein-Kinin system. Front Immunol. 2020;11:2072.","journal-title":"Front Immunol"},{"key":"11598_CR35","doi-asserted-by":"publisher","first-page":"108450","DOI":"10.1016\/j.clim.2020.108450","volume":"215","author":"S Mastaglio","year":"2020","unstructured":"Mastaglio S, Ruggeri A, Risitano AM, et al. The first case of COVID-19 treated with the complement C3 inhibitor AMY-101. Clin Immunol. 2020;215:108450.","journal-title":"Clin Immunol"},{"key":"11598_CR36","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.1523\/JNEUROSCI.0137-10.2010","volume":"30","author":"C Schachtrup","year":"2010","unstructured":"Schachtrup C, Ryu JK, Helmrick MJ, et al. Fibrinogen triggers astrocyte Scar formation by promoting the availability of active TGF-beta after vascular damage. J Neurosci. 2010;30:5843\u201354.","journal-title":"J Neurosci"},{"key":"11598_CR37","doi-asserted-by":"crossref","unstructured":"Geervliet E, Bansal R. Matrix metalloproteinases as potential biomarkers and therapeutic targets in liver diseases. Cells 2020;9:1212.","DOI":"10.3390\/cells9051212"},{"key":"11598_CR38","doi-asserted-by":"publisher","first-page":"642891","DOI":"10.3389\/fimmu.2021.642891","volume":"12","author":"M Rudnik","year":"2021","unstructured":"Rudnik M, Hukara A, Kocherova I, et al. Elevated fibronectin levels in profibrotic CD14(+) monocytes and CD14(+) macrophages in systemic sclerosis. Front Immunol. 2021;12:642891.","journal-title":"Front Immunol"},{"key":"11598_CR39","doi-asserted-by":"publisher","first-page":"6380","DOI":"10.1038\/s41467-023-42140-6","volume":"14","author":"R Erickson","year":"2023","unstructured":"Erickson R, Huang C, Allen C, et al. SARS-CoV-2 infection of human lung epithelial cells induces TMPRSS-mediated acute fibrin deposition. Nat Commun. 2023;14:6380.","journal-title":"Nat Commun"},{"key":"11598_CR40","doi-asserted-by":"crossref","unstructured":"Cantrell R, Feldman HA, Rosenfeldt L et al. Prothrombin prevents fatal T cell-dependent anemia during chronic virus infection of mice. JCI Insight. 2025;10:e18106.","DOI":"10.1172\/jci.insight.181063"},{"key":"11598_CR41","doi-asserted-by":"crossref","unstructured":"Wang C, Liu Y, Liu X et al. IFN-Inducible SerpinA5 triggers antiviral immunity by regulating STAT1 phosphorylation and nuclear translocation. Int J Mol Sci 2023;24:5458.","DOI":"10.3390\/ijms24065458"},{"key":"11598_CR42","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/1040841X.2020.1822279","volume":"46","author":"M Yazdanifar","year":"2020","unstructured":"Yazdanifar M, Mashkour N, Bertaina A. Making a case for using \u03b3\u03b4 T cells against SARS-CoV-2. Crit Rev Microbiol. 2020;46:689\u2013702.","journal-title":"Crit Rev Microbiol"},{"key":"11598_CR43","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.molonc.2013.12.003","volume":"8","author":"Y Jing","year":"2014","unstructured":"Jing Y, Jia D, Wong CM, et al. SERPINA5 inhibits tumor cell migration by modulating the fibronectin-integrin beta1 signaling pathway in hepatocellular carcinoma. Mol Oncol. 2014;8:366\u201377.","journal-title":"Mol Oncol"},{"key":"11598_CR44","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/modpathol.2010.214","volume":"24","author":"IT Bijsmans","year":"2011","unstructured":"Bijsmans IT, Smits KM, de Graeff P, et al. Loss of SerpinA5 protein expression is associated with advanced-stage serous ovarian tumors. Mod Pathol. 2011;24:463\u201370.","journal-title":"Mod Pathol"},{"key":"11598_CR45","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/ijc.22773","volume":"121","author":"K Asanuma","year":"2007","unstructured":"Asanuma K, Yoshikawa T, Hayashi T, et al. Protein C inhibitor inhibits breast cancer cell growth, metastasis and angiogenesis independently of its protease inhibitory activity. Int J Cancer. 2007;121:955\u201365.","journal-title":"Int J Cancer"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11598-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11598-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11598-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:56:50Z","timestamp":1759921010000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11598-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11598"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11598-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by Ethics Committee of Shanghai Public Health Clinical Center (Protocol No. 2023-S077-01, approved on July 4, 2023). Informed consent was obtained from all subjects or their legal next of kin involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1252"}}